|
INN ▲
|
ATC Code ▲
|
Country ▲
|
Classification ▲
|
Last update ▲
|
MA Number ▲
|
Registration date ▲
|
Status ▲
|
|
BRENTUXIMAB VEDOTIN |
L01FX05 |
NL
|
POM
|
27-01-2022 |
|
|
VALID
|
|
COMBINATIONS |
N01BB20 |
NL
|
POM + Exemption
|
02-02-2022 |
|
|
VALID
|
|
GLUCARPIDASE |
V03AF09 |
NL
|
POM
|
29-03-2022 |
|
|
VALID
|
|
ALPELISIB |
L01EM03 |
NL
|
POM
|
25-04-2022 |
|
|
VALID
|
|
TOPOTECAN |
L01CE01 |
NL
|
POM
|
25-04-2022 |
NL/H/1630/001/DC |
31-12-2009 |
VALID
|
|
TAFASITAMAB |
L01FX12 |
NL
|
POM
|
07-06-2022 |
|
|
VALID
|
|
ELECTROLYTES |
B05BB01 |
NL
|
POM
|
08-07-2022 |
NL/H/0545/001/II/016 |
22-01-2009 |
VALID
|
|
LEVOFLOXACIN |
J01MA12 |
NL
|
POM
|
11-07-2022 |
|
|
VALID
|
|
LIDOCAINE |
D04AB01 |
NL
|
Not subject to prescription
|
25-01-2023 |
|
|
VALID
|
|
PHENYLEPHRINE |
S01GA05 |
NL
|
Not authorised
|
25-01-2023 |
|
|
VALID
|
|
AZELASTINE |
S01GX07 |
NL
|
POM + Exemption
|
23-02-2023 |
NL/H/2860/001/ |
17-03-2015 |
VALID
|
|
KETOTIFEN |
S01GX08 |
NL
|
POM
|
23-02-2023 |
NL/H/2430/001/ |
04-10-2012 |
VALID
|
|
CEFUROXIME |
J01DC02 |
NL
|
POM
|
30-05-2023 |
NL/H/2215/003/ |
18-12-2012 |
VALID
|
|
IRINOTECAN |
L01CE02 |
NL
|
POM
|
13-07-2023 |
NL/H/1321/001/ |
17-10-2014 |
VALID
|
|
BRINZOLAMIDE |
S01EC04 |
NL
|
POM
|
18-07-2023 |
NL/H/2715/001/ |
18-02-2015 |
VALID
|
|
FERRIC OXIDE POLYMALTOSE COMPLEXES |
B03AB05 |
NL
|
POM
|
18-07-2023 |
|
|
VALID
|
|
IRON, VITAMIN B12 AND FOLIC ACID |
B03AE01 |
NL
|
Not authorised
|
18-07-2023 |
|
|
VALID
|
|
SACCHARATED IRON OXIDE |
B03AB02 |
NL
|
Not authorised
|
18-07-2023 |
|
|
VALID
|
|
TRAMETINIB |
L01EE01 |
NL
|
POM
|
18-07-2023 |
|
|
VALID
|
|
VARIOUS COMBINATIONS |
B03AE10 |
NL
|
Not authorised
|
19-07-2023 |
|
|
VALID
|
|
VEMURAFENIB |
L01EC01 |
NL
|
POM
|
06-09-2023 |
|
|
VALID
|
|
ESTRADIOL |
G03CA03 |
NL
|
POM
|
07-02-2024 |
NL/H/0280/001/II/015 |
16-08-2008 |
VALID
|
|
CONJUGATED ESTROGENS AND BAZEDOXIFENE |
G03CC07 |
NL
|
POM
|
08-02-2024 |
|
|
VALID
|
|
CYPROTERONE |
G03HA01 |
NL
|
POM
|
08-02-2024 |
NL/H/0623/001/ |
19-02-2015 |
VALID
|
|
PREDNISOLONE |
H02AB06 |
NL
|
POM
|
08-02-2024 |
|
|
VALID
|
|
PROMESTRIENE |
G03CA09 |
NL
|
Not authorised
|
08-02-2024 |
|
|
VALID
|
|
TERLIPRESSIN |
H01BA04 |
NL
|
POM
|
08-02-2024 |
NL/H/2566/001/ |
06-10-2014 |
VALID
|
|
CODEINE |
R05DA04 |
NL
|
POM + Exemption
|
13-02-2024 |
|
|
VALID
|
|
FERRIC CITRATE |
V03AE08 |
NL
|
Not authorised
|
14-05-2024 |
|
|
VALID
|
|
PHENYLBUTAZONE |
M01AA01 |
NL
|
Not authorised
|
14-05-2024 |
|
|
VALID
|
|
OXYGEN |
V03AN01 |
NL
|
POM + Exemption
|
17-05-2024 |
NL/H/2668/001/ |
02-10-2013 |
VALID
|
|
ETRASIMOD |
L04AE05 |
NL
|
POM
|
24-06-2024 |
EMEA/H/C/006007 |
16-02-2024 |
VALID
|
|
FEZOLINETANT |
G02CX06 |
NL
|
POM
|
24-06-2024 |
EMEA/H/C/005851 |
07-12-2023 |
VALID
|
|
GADOPICLENOL |
V08CA12 |
NL
|
POM
|
24-06-2024 |
EMEA/H/C/006172 |
07-12-2023 |
VALID
|
|
LEBRIKIZUMAB |
D11AH10 |
NL
|
POM
|
24-06-2024 |
EMEA/H/C/005894 |
16-11-2023 |
VALID
|
|
MOMELOTINIB |
L01EJ04 |
NL
|
POM
|
24-06-2024 |
EMEA/H/C/005768 |
25-01-2024 |
VALID
|
|
PALOPEGTERIPARATIDE |
H05AA05 |
NL
|
POM
|
24-06-2024 |
EMEA/H/C/005934 |
17-11-2023 |
VALID
|
|
PEGZILARGINASE |
A16AB24 |
NL
|
POM
|
24-06-2024 |
EMEA/H/C/005484 |
15-12-2023 |
VALID
|
|
QUIZARTINIB |
L01EX11 |
NL
|
POM
|
24-06-2024 |
EMEA/H/C/005910 |
06-11-2023 |
VALID
|
|
REZAFUNGIN |
J02AX08 |
NL
|
POM
|
24-06-2024 |
EMEA/H/C/005900 |
22-12-2023 |
VALID
|
|
ROZANOLIXIZUMAB |
L04AG16 |
NL
|
POM
|
24-06-2024 |
EMEA/H/C/005824 |
05-01-2024 |
VALID
|
|
TRASTUZUMAB |
L01XC03 |
NL
|
POM
|
24-06-2024 |
EMEA/H/C/005769 |
15-11-2023 |
VALID
|
|
VAMOROLONE |
H02AB18 |
NL
|
POM
|
24-06-2024 |
EMEA/H/C/005679 |
14-12-2023 |
VALID
|
|
ZILUCOPLAN |
L04AJ06 |
NL
|
POM
|
24-06-2024 |
EMEA/H/C/005450 |
01-12-2023 |
VALID
|
|
BUDESONIDE |
A07EA06 |
NL
|
POM
|
23-07-2024 |
|
|
VALID
|
|
EPINEPHRINE |
C01CA24 |
NL
|
POM
|
26-07-2024 |
|
|
VALID
|
|
CARVEDILOL |
C07AG02 |
NL
|
POM
|
29-07-2024 |
|
|
VALID
|
|
GLYCERYL TRINITRATE |
C01DA02 |
NL
|
POM
|
29-07-2024 |
|
|
VALID
|
|
PODOPHYLLOTOXIN |
D06BB04 |
NL
|
POM
|
30-07-2024 |
|
|
VALID
|
|
GANIRELIX |
H01CC01 |
NL
|
POM
|
31-07-2024 |
|
|
VALID
|